81, Irwon- Ro
Gangnam-gu
Seoul, 135-710
Korea, Republic of (South Korea)
Sungkyunkwan University - Samsung Medical Center
Ovarian Neoplasms, Platinum-resistant, BRCA wild type, PARP inhibitor, Immunotherapy
Uterine carcinosarcoma, Recurrent endometrial cancer, Immunotherapy, Pembrolizumab, Real-world data
borderline ovarian tumor, fertility-sparing surgery, ovarian cystectomy, propensity score overlap weighting